ClinicalTrials.Veeva

Menu

Evaluating Non-Invasive Haptics During Extreme Exercise (ENDURE)

S

SuperPatch Limited LLC

Status

Invitation-only

Conditions

VO2max
Lactate
Lactate Threshold

Treatments

Device: Sham patch
Device: Victory Patch with Haptic Vibrotactile Trigger Technology

Study type

Interventional

Funder types

Industry
Other

Identifiers

NCT07285252
ENDURE-001

Details and patient eligibility

About

This study aims to compare determinants of endurance performance between participants wearing an active patch with haptic vibrotactile trigger technology (VTT) versus a placebo patch without VTT among recreational to competitive runners over a 4-week training period.

Enrollment

75 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 years and over, that participate in recreational to competitive distance running (>2 structured runs per week), that were able to complete maximal treadmill exercise safely and were able to attend three laboratory visits were invited to participate.

Exclusion criteria

  • Adults with a contraindications to high-intensity treadmill exercise, cardiovascular, metabolic, or musculoskeletal conditions limiting participation, reported use of performance-enhancing drugs, pregnancy, known allergy to adhesives, or current use of neuromodulatory or haptic devices

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

75 participants in 2 patient groups, including a placebo group

TREATMENT
Active Comparator group
Description:
Victory Patch
Treatment:
Device: Victory Patch with Haptic Vibrotactile Trigger Technology
CONTROL
Placebo Comparator group
Description:
Sham Comparator
Treatment:
Device: Sham patch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems